Crowdfunding is on the rise. And experience shows that it may not coexist independently of more traditional funding mechanism. Rather, crowdfunding could soon be one more feature among the many combinations of funding sources sought to do research. But there is plenty of details to iron out before scientists can make the most of crowdfunding. Read more […]
Text and data mining (TDM) techniques are increasingly used by researchers to explore the tremendous amount of scholarly publications. By automating this type of search, scientists can have an edge over competing teams. Yet, new copyright legislation due to be discussed later on this year in Europe, could hamper their work. Read more […]
The debate about reproducibility studies is becoming more and more high-profile. The open data movement is helping science become more reproducible but there is still scant reward – academic or financial – for scientists who try to reproduce published science. Reproducibility studies, and increasingly post-publication peer-review, are at the heart of scientific research and such work should be counted as a positive factor in academic evaluations. Here we find out how that could work. Read more […]
Reproducibility of research is at the heart of science. However, old habits die hard. And the custom of making all data fully available so that others can reproduce them is not yet fully ingrained in scientists’ modus operandi. Some likely changes that may encourage data sharing include the introduction of training modules on good sharing practice and the practice of crediting the author of the original data set used in new work. These could go a long way towards unlocking the reproducibility challenge. Read more […]
Representing molecules and cells has always been in a challenge. Thanks for computer graphics and the availability of cartoon-style rendering, David Goodsell from the Scripps Research Institute, has created a new visual universe than enhances our understanding of what proteins actually look like. Read more […]
The ongoing opposition between the scientific community and science publishers is evolving. The latter have tarnished their reputation on the count of greed and inability to give back to the community. Now, however, grassroots innovators and legacy publishers have started to develop tech-centric solutions to better serve the community. These could soon make a noticeable difference to the scientific process itself and bring tangible benefits to scientists. Time will tell whether the tide will turn and trust between the protagonists will return. Read more […]
Fashion is not commonly associated with science and technology. However, there has always been a close connection between these fields. Exploring the way both fields have evolved, finding synergies, brings some interesting insights into how technology can have a direct influence on the way people live. But it could also impinge on their right to privacy. Read more […]
Read about the challenges that Stephane Huberty, an entrepreneur who is also a medical doctor, since he was diagnosed with myasthenia gravis (MG). This article accounts of the many meanders that he had to face on the path to bringing a disruptive innovation–a vaccine for MG–towards the market. This demonstrates that in innovation circles, there is no one-size-fits-all and that some innovations may not quite fit the existing innovation system as expected. Read more […]
When it comes to mobility, Central and Eastern European scientists are among the champions. This has often resulted in an entire generational gap in their country’s scientific community. Now, some of the brainiest Eastern European scientists are doing research in the most dynamic research hubs in Western Europe, the US and Asia. And their home countries are left to pick up the pieces. Read more […]
Central and Eastern Europe is proving very attractive to pharma and biotech companies for clinical trials. Highly motivated patients, well-qualified investigators, speed of trials and quality of data as well as lower costs are frequently listed attractions. All together, the population of Central and Eastern Europe represents greater number of people than that of either the United States or the five largest Western European markets combined. Besides, the region also offers a convenient location—at the heart of Europe—for drug and device industries to carry out clinical trials. This article explore in many details the many reasons that makes life science industry come back over and over again to these territories, which have gained their reputation through a combination of rigour, high education levels and historic legacy. Read more […]
Poland’s recent past has seen the emergence of an entrepreneurial generation over a period of 25 years of reforms and 10 years in the European Union. Poland is now considered one of the most dynamic economies of the EU. Read more […]
The internet is transforming the way researchers communicate. And the pace of change is increasing. A number of issues have arisen under increasing public scrutiny. These include peer-review transparency, open data, evaluation of research impact—both based on articles and authors—as well as research reproducibility. At the same time, demand for real time Open Access (OA) to the latest scientific and medical results has rocketed. Read more […]
European science conversations by the community, for the community
